Philip Hampton

British Association of Dermatologists’ guidelines for the management of pemphigus vulgaris 2017

Kristyn Harman, D. Brown, L.S. Exton et al. · British Journal of Dermatology · 2017 · 241 citations · Full text

Language Documentation, British Association, Lexical Resource +13

Doxycycline versus prednisolone as an initial treatment strategy for bullous pemphigoid: a pragmatic, non-inferiority, randomised controlled trial

Hywel C Williams, Fenella Wojnarowska, Gudula Kirtschig et al. · The Lancet · 2017 · 212 citations · Full text

Factors associated with adverse COVID-19 outcomes in patients with psoriasis—insights from a global registry–based study

Satveer K. Mahil, Nick Dand, K.J. Mason et al. · Journal of Allergy and Clinical Immunology · 2020 · 158 citations · Full text

Adverse Covid-19 Outcomes, Global Health, Covid-19 Pandemic +9

Drug survival of adalimumab, ustekinumab and secukinumab in patients with psoriasis: a prospective cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR)

Zenas Z N Yiu, K.J. Mason, Philip Hampton et al. · British Journal of Dermatology · 2020 · 105 citations · Full text

Comparison of Drug Discontinuation, Effectiveness, and Safety Between Clinical Trial Eligible and Ineligible Patients in BADBIR

K.J. Mason, Juliet N. Barker, Catherine Smith et al. · JAMA Dermatology · 2018 · 100 citations · Full text